Sterile Injectable Drugs: Global Market Sales, Consumption, Demand
and Forecast 2017 to 2023- Planet Market Reports
Global Sterile Injectable Market Report Description:
Sterile Injectable market report gives comprehensive outlook on sterile injectable across the globe
with special emphasis on key regions such as North America, Europe, AsiaPacific, Latin America,
and Middle East & Africa MEA. This report on sterile injectable market gives historical, current, and
future market sizes US$ Mn of drug molecules, drug types, disease application, route of
administration, end users, and geographic regions. This report studies sterile injectable market
dynamics elaborately to identify the current trends & drivers, future opportunities and possible
challenges to the key stakeholders operating in the market. In addition, sterile injectable market
report includes drug pipeline analysis, regulatory scenario, and competition analysis with vividly
illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed
sterile injectable market to better equip clients with possible investment opportunities across the
regions Regional Investment HotSpots and market unmet needs Product Opportunities. Key
stakeholders of the sterile injectable market report include suppliers, manufacturers, marketers,
policy makers engaged in manufacturing and supply of sterile injectable .
Sterile Injectable Market:
The sterile injectable market estimated to be valued US$ 361 Bn in 2016 and poised to grow at
CAGR 7.3%. Market for sterile injectable projected to reach US$ 552 Bn by 2023.
Do the burgeoning product pipelines and drug patent expiries have positive impact on the market?
The rising shift of pharmaceutical and biotechnology firms towards the development of medications
for chronic diseases such as cancer, diabetes, and cardio vascular and among others have created
ample growth opportunities for players in the market. Moreover, biologic have become larger part of
product pipelines of several drug developers, which could affect market growth positively over the
forecast period. For instance, there are around 2,500 injectable products are in developmental
stage. Moreover, rising product patent expiries of several blockbuster in recent times expected to
propel market growth over the forecast period. For instance in 2015, Teva Pharmaceutical Industries
Ltd. lost patent for its top selling multiple sclerosis drug Copaxone.
How operational and installation cost effects the sterile injectable market?
Several industry experts noted that the cost of establishing sterile injectable plants is significantly
higher vizaviz non sterile manufacturing plants owing to stringent aseptic requirements and complex
manufacturing process; this has led to the consolidation of the industry by backward and forward
integration. Moreover, competition from low cost manufacturers, value chain integration coupled with
high entry barrier for new players in sterile injectable market expect impact market growth negatively